This month, G20 finance ministers and central bank governors will be discussing a new financing vehicle to help all countries develop the capacity to stop future health emergencies before they get out of hand. But success ultimately will depend on whether they can embrace new governance principles and methods.
WASHINGTON, DC – With over two-thirds of the African continent still unvaccinated against COVID-19, it is clear that the global pandemic preparedness and response (PPR) regime remains seriously underfunded and lacking in resilient, effective delivery systems. While the World Health Organization’s Access to COVID-19 Tools Accelerator (ACT-A) has helped to address the gross inequity in access to testing, treatments, and vaccines, it lacks the financial backing needed to support low-income countries comprehensively.
Scientific and economic research has shown that a future air-borne pandemic could kill millions of people and cause economic chaos, especially in the context of increased urbanization and intensifying climate change. The emergence of another novel pathogen is inevitable, and when it comes, it could well pose an existential threat to humanity. As with the battle against global warming, the costs of inaction are much greater than the costs of action.
Last October, the Italian G20 Presidency issued a PPR roadmap to ensure that the world is better prepared for the next global health challenge. In the coming days, G20 finance ministers and central bank governors will receive a progress report from the G20 Joint Finance and Health Task Force, the body created to monitor performance.
A crucial next step is to create an effective, properly funded Financial Intermediary Fund (FIF). The WHO and the World Bank estimate that there is at least a $10.5 billion annual financing gap for PPR. We should regard that as the bare minimum amount of additional financing required each year to support equitable access to vaccines, testing and therapies, pathogen surveillance, research and development, manufacturing, and health infrastructure.
There is no good reason why the G20 should not be able to muster another $10.5 billion per year. It is a tiny fraction of the trillions of dollars deployed to mitigate the current pandemic, not to mention the trillions that would be lost in the event of another global health crisis.
Still, to succeed, the FIF must also meet four specific conditions. First, it should not be financed through occasional pledging or replenishment initiatives, as these are too unreliable. Instead, governments must agree to provide the first five years of funding up front, while taking steps to build financial commitments to the FIF into their annual budgets.
CYBER MONDAY SALE: Subscribe for as little as $34.99
Last chance to save! Subscribe now to gain access to insights and analyses from the world’s leading thinkers – starting at just $34.99 for your first year.
Subscribe Now
This starter fund should promote innovative and blended finance mechanisms to leverage the FIF’s investments. There is no need to reinvent the wheel here. Governments, development banks, philanthropists, and corporations are already creating new partnerships to achieve net-zero emissions goals. G20 leaders should establish an expert group to identify best practices from green financing models that could be deployed for investments in PPR.
Moreover, because low- and middle-income countries face tight fiscal constraints, any additional investments they make in their public-health and PPR systems should be recognized as in-kind contributions to the FIF (provided they are compatible with the fund’s overall objectives).
Second, the FIF must have an evaluation mechanism, based on agreed metrics of an investment’s socioeconomic impact, to ensure the efficient use of these new resources. Any such mechanism must give donors confidence that there is a measurable return on their long-term commitment to the FIF.
Third, the FIF’s funding must not undermine programs that are addressing other urgent public health needs. High-income countries’ contributions must be made in addition to existing official development assistance to ensure that the FIF isn’t poaching support.
Lastly, as the G20 Rome Leaders’ Declaration recognized, the FIF must aim for universal access and inclusive governance to ensure that it has legitimacy in the eyes of low- and middle-income countries. For example, pharmaceutical innovation and production should be governed according to the principle of collective intelligence, which calls for the widest possible sharing of the underlying knowledge.
The FIF must move away from an outdated and inequitable donor-beneficiary framework. Representation within the FIF’s formal governance structure should be distributed equally across high-, middle-, and low-income countries. There should also be a core of global and regional implementing institutions, such as the WHO and Africa Centers for Disease Control, as well as representation by independent experts from across society.
To avoid bureaucratic disputes between global governance bodies, the FIF should be hosted by the World Bank, with the WHO playing a leading role in strategy development and execution. At the same time, both organizations must recognize that the best way to build expertise and capacity is to encourage the widest involvement of all stakeholders in fully transparent partnerships.
This year’s Indonesian G20 Presidency must ensure that the FIF comes to fruition. But first, those gathering this month for the spring World Bank and International Monetary Fund meetings must agree on the financing and architecture, ensuring that the FIF meets the four conditions outlined above.
If the COVID-19 pandemic has shown us anything, it is that we need a radical change in direction. A well-designed, fully funded PPR fund is a crucial step on the way to achieving the WHO’s mission of Health For All.
To have unlimited access to our content including in-depth commentaries, book reviews, exclusive interviews, PS OnPoint and PS The Big Picture, please subscribe
In recent years, a growing chorus of academics and policymakers has sounded the alarm over the systemic dysfunction of the US tech sector. Yet, despite the high drama of congressional hearings with Big Tech CEOs and a cascade of bills promising comprehensive reforms, the results have been disappointing.
worry that in its bid to outcompete China, the US risks stifling its own potential for innovation.
As Germany and France head into another year of near-zero growth, it is clear that Keynesian stimulus alone cannot pull them out of their current malaise. To regain the dynamism and flexibility needed to weather US President-elect Donald Trump’s tariffs, Europe’s largest economies must pursue far-reaching structural reforms.
explains why the EU’s long-term economic slump is not likely to end anytime soon.
Log in/Register
Please log in or register to continue. Registration is free and requires only your email address.
WASHINGTON, DC – With over two-thirds of the African continent still unvaccinated against COVID-19, it is clear that the global pandemic preparedness and response (PPR) regime remains seriously underfunded and lacking in resilient, effective delivery systems. While the World Health Organization’s Access to COVID-19 Tools Accelerator (ACT-A) has helped to address the gross inequity in access to testing, treatments, and vaccines, it lacks the financial backing needed to support low-income countries comprehensively.
Scientific and economic research has shown that a future air-borne pandemic could kill millions of people and cause economic chaos, especially in the context of increased urbanization and intensifying climate change. The emergence of another novel pathogen is inevitable, and when it comes, it could well pose an existential threat to humanity. As with the battle against global warming, the costs of inaction are much greater than the costs of action.
Last October, the Italian G20 Presidency issued a PPR roadmap to ensure that the world is better prepared for the next global health challenge. In the coming days, G20 finance ministers and central bank governors will receive a progress report from the G20 Joint Finance and Health Task Force, the body created to monitor performance.
A crucial next step is to create an effective, properly funded Financial Intermediary Fund (FIF). The WHO and the World Bank estimate that there is at least a $10.5 billion annual financing gap for PPR. We should regard that as the bare minimum amount of additional financing required each year to support equitable access to vaccines, testing and therapies, pathogen surveillance, research and development, manufacturing, and health infrastructure.
There is no good reason why the G20 should not be able to muster another $10.5 billion per year. It is a tiny fraction of the trillions of dollars deployed to mitigate the current pandemic, not to mention the trillions that would be lost in the event of another global health crisis.
Still, to succeed, the FIF must also meet four specific conditions. First, it should not be financed through occasional pledging or replenishment initiatives, as these are too unreliable. Instead, governments must agree to provide the first five years of funding up front, while taking steps to build financial commitments to the FIF into their annual budgets.
CYBER MONDAY SALE: Subscribe for as little as $34.99
Last chance to save! Subscribe now to gain access to insights and analyses from the world’s leading thinkers – starting at just $34.99 for your first year.
Subscribe Now
This starter fund should promote innovative and blended finance mechanisms to leverage the FIF’s investments. There is no need to reinvent the wheel here. Governments, development banks, philanthropists, and corporations are already creating new partnerships to achieve net-zero emissions goals. G20 leaders should establish an expert group to identify best practices from green financing models that could be deployed for investments in PPR.
Moreover, because low- and middle-income countries face tight fiscal constraints, any additional investments they make in their public-health and PPR systems should be recognized as in-kind contributions to the FIF (provided they are compatible with the fund’s overall objectives).
Second, the FIF must have an evaluation mechanism, based on agreed metrics of an investment’s socioeconomic impact, to ensure the efficient use of these new resources. Any such mechanism must give donors confidence that there is a measurable return on their long-term commitment to the FIF.
Third, the FIF’s funding must not undermine programs that are addressing other urgent public health needs. High-income countries’ contributions must be made in addition to existing official development assistance to ensure that the FIF isn’t poaching support.
Lastly, as the G20 Rome Leaders’ Declaration recognized, the FIF must aim for universal access and inclusive governance to ensure that it has legitimacy in the eyes of low- and middle-income countries. For example, pharmaceutical innovation and production should be governed according to the principle of collective intelligence, which calls for the widest possible sharing of the underlying knowledge.
The FIF must move away from an outdated and inequitable donor-beneficiary framework. Representation within the FIF’s formal governance structure should be distributed equally across high-, middle-, and low-income countries. There should also be a core of global and regional implementing institutions, such as the WHO and Africa Centers for Disease Control, as well as representation by independent experts from across society.
To avoid bureaucratic disputes between global governance bodies, the FIF should be hosted by the World Bank, with the WHO playing a leading role in strategy development and execution. At the same time, both organizations must recognize that the best way to build expertise and capacity is to encourage the widest involvement of all stakeholders in fully transparent partnerships.
This year’s Indonesian G20 Presidency must ensure that the FIF comes to fruition. But first, those gathering this month for the spring World Bank and International Monetary Fund meetings must agree on the financing and architecture, ensuring that the FIF meets the four conditions outlined above.
If the COVID-19 pandemic has shown us anything, it is that we need a radical change in direction. A well-designed, fully funded PPR fund is a crucial step on the way to achieving the WHO’s mission of Health For All.